
A new skin cancer therapy found by Chinese scientists
Cutaneous squamous cell carcinoma (cSCC) is the most prevalent kind of skin cancer and the second most common tumor of the cells at the base of the outer layer of the skin. By studying the […]
Cutaneous squamous cell carcinoma (cSCC) is the most prevalent kind of skin cancer and the second most common tumor of the cells at the base of the outer layer of the skin. By studying the […]
Chromophobe renal cell carcinoma (CHRCC) is the third most prevalent kind of renal cell carcinoma, accounting for 5% of all kidney carcinomas. Clinically, it is known for having a favorable prognosis compared to the most […]
Increasing evidence reveals that ferroptosis, or iron-dependent cell death, and pyroptosis, an inflammatory form of cell death that happens most commonly upon infection, play pivotal roles in the development of a kind of brain tumor […]
Osteoarthritis (OA) of the knee is the most common form of arthritis characterized by the degeneration of articular cartilage and the formation of bone spurs. The goals for OA treatment are to reduce pain, slow […]
We are proud to announce that the Reviewer of the Month Award for March 2022 goes to Dr. Diogo Goulart Correa. As a means to promote the hard work and dedication invested “behind the scenes” […]
Development of limbs starts with embryonic-outhgrowths, first with front- and then with hind-limb buds. The regulation of limb-bud development, including cartilage differentiation, is highly complicated as it depends on activating or silencing many genes and […]
Alzheimer’s disease (AD) is the major subtype of dementia and the most common progressive neurodegenerative disease in which the central nervous system cells stop working or die. Neuroinflammation is one of the pathogenic factors in […]
Preterm birth (PTB) is defined as a birth that occurs between 20 and 36(+6) weeks of pregnancy. Preterm birth is a leading cause of morbidity and mortality, with a great cost to society, and an […]
V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel negative immune checkpoint that has been linked to immunotherapy resistance and might be used as a therapeutic target. It is found overexpressed in non-small cell […]
We are proud to announce that the Reviewer of the Month Award for February 2022 goes to Dr. Wayne J.G. Hellstrom. As a means to promote the hard work and dedication invested “behind the scenes” […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH